These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10166411)

  • 21. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden.
    Unge P; Jönsson B; Stålhammar NO
    Pharmacoeconomics; 1995 Nov; 8(5):410-27. PubMed ID: 10160075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of Helicobacter pylori eradication therapies in patients with duodenal ulcer. An analysis of triple therapy versus two dual therapy alternatives.
    Tennvall GR; Norinder A; Ohlin B
    Pharmacoeconomics; 1999 Sep; 16(3):297-306. PubMed ID: 10558041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
    Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
    Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G
    Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Esomeprazole in treating duodenal ulcer in various modes of anti-Helicobacter therapy].
    Maev IV; Kurilo AE; V'iuchnova ES; Shchekina MI
    Ter Arkh; 2003; 75(2):23-6. PubMed ID: 12685385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer.
    Catalano F; Terminella C; Branciforte G; Bentivegna C; Brogna A; Scalia A
    Digestion; 2002; 66(3):154-9. PubMed ID: 12481161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
    O'Brien B; Goeree R; Mohamed AH; Hunt R
    Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
    Huang WH; Ho AS; Shyu RY; Lee SC; Lee MM; Hsu CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):448-55. PubMed ID: 9745160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
    Carrère MO; Auquier P; Poynard T; Sambuc R
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H; Perie F; Joubert-Collin M
    Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sucralfate in Helicobacter pylori eradication strategies.
    Lam SK; Hu WH; Ching CK
    Scand J Gastroenterol Suppl; 1995; 210():89-91. PubMed ID: 8578217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
    Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Helicobacter pylori: 6-day triple therapy in duodenal ulcer].
    Sanfélix Genovés J; Pereiró Berenguer I; Jimeno Bernard R; García Tell G; Navarro Pérez J; Bonet Pla A; Ballester Belenguer J
    Aten Primaria; 1998 May; 21(8):517-21. PubMed ID: 9670578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?].
    Gisbert JP; Boixeda D; Bermejo F; Moreno L; Ramos F; Martín de Argila C; García Arata I; García Plaza A
    Rev Clin Esp; 1998 Oct; 198(10):655-9. PubMed ID: 9844453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
    Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
    Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.